Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human Pappalysin-1/PAPP-A (aa 82-1627)

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Supplier:  R&D Systems™ 2487ZNF020

Catalog No. 2487ZNF020


Add to Cart
This item is not returnable. View return policy

Description

Description

Measured by its ability to cleave IGFBP-5. Recombinant Human Pappalysin-1/PAPP-A will cleave >50% of Recombinant Human IGFBP-5 (Catalog # 875-B5 ), as measured under the described conditions.
Specifications

Specifications

Q13219
Supplied as a 0.2 μm filtered solution in Tris, NaCl, CaCl2, and CHAPS.
M.W. (Observed): 139-238 kDa, three bands, reducing conditions; M.W. (theoretical): 173 kDa
20 μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20°C to -70°C as supplied. 3 months, -20°C to -70°C under sterile conditions after opening.
PAPPA
Recombinant
Pappalysin-1/PAPP-A
Enzyme Activity
5069
Pappalysin-1/PAPP-A aa 82-1627
Mouse myeloma cell line, NS0-derived human Pappalysin-1/PAPP-A protein Glu82-Gly1627 (S1224Y), with a C-terminal 6-His tag
<1.0 EU / 1 μg of the protein by the LAL method.
Unconjugated
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit